ABG

Ally Bridge Group Portfolio holdings

AUM $114M
This Quarter Return
+8.7%
1 Year Return
+41.64%
3 Year Return
+246.39%
5 Year Return
–
10 Year Return
–
AUM
$187M
AUM Growth
+$187M
Cap. Flow
+$18.6M
Cap. Flow %
9.98%
Top 10 Hldgs %
49.27%
Holding
34
New
9
Increased
10
Reduced
10
Closed
5

Top Buys

1
TARS icon
Tarsus Pharmaceuticals
TARS
$10.6M
2
RVMD icon
Revolution Medicines
RVMD
$7.41M
3
SWTX
SpringWorks Therapeutics
SWTX
$7.3M
4
ELVN icon
Enliven Therapeutics
ELVN
$6M
5
APLT icon
Applied Therapeutics
APLT
$5.26M

Top Sells

1
SLNO icon
Soleno Therapeutics
SLNO
$11.7M
2
LEGN icon
Legend Biotech
LEGN
$8.64M
3
DAWN icon
Day One Biopharmaceuticals
DAWN
$7.39M
4
GERN icon
Geron
GERN
$6.38M
5
AVDL
Avadel Pharmaceuticals
AVDL
$6.05M

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
TRVI icon
26
Trevi Therapeutics
TRVI
$871M
$4.42M 2.37%
1,322,800
-152,126
-10% -$508K
PRAX icon
27
Praxis Precision Medicines
PRAX
$980M
$4.21M 2.25%
73,185
-80,194
-52% -$4.61M
CNTX icon
28
Context Therapeutics
CNTX
$75.6M
$3.44M 1.84%
1,757,524
-128,708
-7% -$252K
PMN icon
29
ProMIS Neurosciences
PMN
$23.7M
$1.99M 1.07%
1,592,605
+533,023
+50% +$666K
SLNO icon
30
Soleno Therapeutics
SLNO
$3.56B
– –
-286,162
Closed -$11.7M
LEGN icon
31
Legend Biotech
LEGN
$6.64B
– –
-195,000
Closed -$8.64M
DAWN icon
32
Day One Biopharmaceuticals
DAWN
$766M
– –
-536,095
Closed -$7.39M
BDTX icon
33
Black Diamond Therapeutics
BDTX
$164M
– –
-835,000
Closed -$3.89M
AVDL
34
Avadel Pharmaceuticals
AVDL
$1.42B
– –
-430,245
Closed -$6.05M
1
2